Real-world survival and treatment regimens across first- to third-line treatment for advanced triple-negative breast cancer
Last Updated: Monday, October 30, 2023
This observational study looked at outcomes and treatment patterns of 243 patients with advanced metastatic or locally recurrent TNBC in Denmark. To validate the optimal treatment for patients with metastatic triple-negative breast cancer, real-world evidence in combination with data from clinical trials must be evaluated as complementary.
Advertisement
News & Literature Highlights